Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma
      Description

      The purpose of this study is to evaluate the anti-tumor activity of alisertib (MLN8237) in participants with relapsed or refractory non-hodgkin's lymphoma.

      Conditions
      Diffuse Large B-cell LymphomaMantle Cell LymphomaBurkitt's LymphomaT-cell Lymphoma, Excluding Primary Cutaneous T-cell LymphomaTransformed Follicular Lymphoma With ≥ 50% Diffuse Large Cell Component
      Talk to us